arrow_back Back Filing freshness 10-Q Q2 FY2027 SEC EDGAR

NutriBand Inc.

NTRB
$7.36 ▲ +0.46 (+6.59%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
43 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
9
Health
Poor
Bearish
auto_awesome

Analytical Summary

NutriBand Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $89.5M
Dividend Yield
Revenue Growth -29.7%
Op. Margin -203.6%
ROIC -13.2%
FCF / Share $-0.05
Trailing P/E
Price / Book 16.8x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

43-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$437.51K
↓ -29.7%
Net Income Profit after all expenses
$-880.56K
↑ +56.0%
Operating Margin Operating profit as % of sales
-203.6%
↑ +29.7% 0th
FCF / Share Free cash flow per share
$-0.05
↓ -3.9%
Long-Term Debt Long-term obligations
$1.70K
↓ -1.4%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
0
Returns
5
Financial Health
7
Cash Quality
42

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 11 years · 43 quarters